NK cells Clinical Trials

3 actively recruiting trials across 3 locations

No change since May 2026

Pipeline

Phase 1: 2Phase 1/2: 1

Top Sponsors

M.D. Anderson Cancer Center2
Nationwide Children's Hospital1

Indications

Cancer3
Carcinomatosis1
Peritoneal Metastases1
Acute Myeloid Leukemia1
High Grade Glioma1

Cleveland, Ohio1 trial

A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)

Case Western Reserve University

Phase 1

Columbus, Ohio1 trial

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Nationwide Children's Hospital

Phase 1

Houston, Texas1 trial

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.